Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jan-Mar;24(1):24-29.
doi: 10.4103/meajo.MEAJO_255_16.

Risks of Cefuroxime Prophylaxis for Postcataract Endophthalmitis

Khaled A Al-Abduljabbar  1   2 , Donald U Stone  1   3
Affiliations

Risks of Cefuroxime Prophylaxis for Postcataract Endophthalmitis

Khaled A Al-Abduljabbar et al. Middle East Afr J Ophthalmol. 2017 Jan-Mar.

Abstract

Background: Endophthalmitis after cataract surgery is a rare but vision-threatening complication. Intracameral cefuroxime (ICC) has been reported to be effective at reducing the risk, but concerns regarding the risks associated with this intervention remain.

Methods: Systematic review and synthesis of the literature on ICC, with a focus on the risks of therapy.

Results: Level 2a evidence was found to support the use of cefuroxime in penicillin-allergic patients. Compounding or dilutional errors are associated with ocular toxicity, but the incidence and risk of this occurrence are unknown. Level 4 evidence supports interventions that reduce the risk of dilutional errors. The association of cefuroxime injection with toxic anterior segment syndrome (TASS) is not established; Level 5 evidence supports standard measures to reduce the incidence of TASS related to cefuroxime administration.

Conclusion: Cefuroxime can be administered safely to penicillin-allergic patients, and steps should be taken to reduce the risk of compounding or dilutional errors to avoid negating the benefits of this intervention. Recommended practice patterns for endophthalmitis prophylaxis should consider the risks and benefits of ICC.

Keywords: Cataract; cefuroxime; endophthalmitis; practice pattern; risk.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Similar articles

See all similar articles

Cited by

References

    1. Miller JJ, Scott IU, Flynn HW, Jr, Smiddy WE, Newton J, Miller D. Acute-onset endophthalmitis after cataract surgery (2000-2004): Incidence, clinical settings, and visual acuity outcomes after treatment. Am J Ophthalmol. 2005;139:983–7. - PubMed
    1. Taban M, Behrens A, Newcomb RL, Nobe MY, Saedi G, Sweet PM, et al. Acute endophthalmitis following cataract surgery: A systematic review of the literature. Arch Ophthalmol. 2005;123:613–20. - PubMed
    1. Schwartz SG, Grzybowski A, Flynn HW., Jr Antibiotic prophylaxis: Different practice patterns within and outside the United States. Clin Ophthalmol. 2016;10:251–6. - PMC - PubMed
    1. Endophthalmitis Study Group, European Society of Cataract & Refractive Surgeons. Prophylaxis of postoperative endophthalmitis following cataract surgery: Results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg. 2007;33:978–88. - PubMed
    1. Barreau G, Mounier M, Marin B, Adenis JP, Robert PY. Intracameral cefuroxime injection at the end of cataract surgery to reduce the incidence of endophthalmitis: French study. J Cataract Refract Surg. 2012;38:1370–5. - PubMed

Publication types

MeSH terms